Heidelberg Pharma AG (HPHA) | WebDisclosure

Basculer en Français

8295	Companies
114863	Keywords
55304	Articles
62446	Press releases

Home
Companies
Heidelberg Pharma AG

BRIEF

published on 10/01/2024 at 17:34, 1 month 19 days ago

Heidelberg Pharma présente des données cliniques prometteuses pour le candidat ADC phare HDP-101

Heidelberg Pharma HDP-101 Myélome Multiple ADC Données Cliniques
PRESS RELEASE

published on 10/01/2024 at 17:29, 1 month 19 days ago

Heidelberg Pharma: New Clinical Data on Lead ADC Candidate HDP-101 Presented at IMS 2024 Demonstrating Complete Remission in One Patient
Heidelberg Pharma presents new clinical data on lead ADC candidate HDP-101 at IMS 2024, showing complete remission in one patient. Company developing innovative ADCs for cancer treatment

Clinical Data Heidelberg Pharma ADC IMS 2024 Complete Remission
BRIEF

published on 10/01/2024 at 15:32, 1 month 19 days ago

Heidelberg Pharma AG annonce une mise à jour de ses prévisions financières

Heidelberg Pharma Orientations Mises À Jour Dépenses D'exploitation Exercice Financier 2024 Besoins En Liquidités
BRIEF

published on 10/01/2024 at 15:32, 1 month 19 days ago

Heidelberg Pharma AG Announces Updated Financial Guidance

Financial Year 2024 Heidelberg Pharma Operating Expenses Updated Guidance Cash Requirements
PRESS RELEASE

published on 10/01/2024 at 15:27, 1 month 19 days ago

EQS-Adhoc: Heidelberg Pharma AG Announces Updated Guidance
Heidelberg Pharma AG adjusts its 2024 guidance, expecting sales and other income between EUR 10.0 - 12.0 million and operating expenses between EUR 30.0 - 33.0 million. The company anticipates secured financing until mid-2025

Financial Year Heidelberg Pharma AG Operating Expenses Updated Guidance Secured Financing
BRIEF

published on 09/23/2024 at 13:10, 1 month 27 days ago

Heidelberg Pharma présentera de nouvelles données cliniques sur HDP-101 à l'IMS 2024

Heidelberg Pharma HDP-101 Myélome Multiple Données Cliniques IMS 2024
BRIEF

published on 09/23/2024 at 13:10, 1 month 27 days ago

Heidelberg Pharma to Present New Clinical Data on HDP-101 at IMS 2024

Clinical Data Heidelberg Pharma HDP-101 Multiple Myeloma IMS 2024
PRESS RELEASE

published on 09/23/2024 at 13:05, 1 month 27 days ago

Heidelberg Pharma Announces New Clinical Data on Lead ATAC Candidate HDP-101 to be Presented at International Myeloma Society Annual Meeting 2024
Heidelberg Pharma announces new clinical data on lead ATAC candidate HDP-101 to be presented at International Myeloma Society Annual Meeting 2024

Clinical Data Heidelberg Pharma HDP-101 ATAC Candidate Myeloma Society
BRIEF

published on 07/11/2024 at 07:10, 4 months 10 days ago

Heidelberg Pharma rend compte du premier semestre 2024 et de la marche des affaires

Résultats Financiers Essai Clinique Heidelberg Pharma HDP-101 Myélome Multiple
BRIEF

published on 07/11/2024 at 07:10, 4 months 10 days ago

Heidelberg Pharma Reports on First Half-Year 2024 and the Course of Business

Financial Results Clinical Trial Heidelberg Pharma HDP-101 Multiple Myeloma

Accesswire

Published on 11/21/2024 at 12:00, 47 minutes ago

Alset AI Announces Full Repayment of $3.7 Million Secured Loan with Interest from Portfolio Company, Significantly Strengthening Balance Sheet
Published on 11/21/2024 at 12:00, 47 minutes ago

Battery X Metals Commences Strategic Initiatives to Strengthen Balance Sheet
Published on 11/21/2024 at 11:30, 1 hour 17 minutes ago

FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 2 hours 44 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 2 hours 47 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 12:35, 12 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 32 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 40 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 47 minutes ago

Holding(s) in Company
Published on 11/21/2024 at 11:30, 1 hour 17 minutes ago

APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived

Les Echos

Published on 11/21/2024 at 06:58, 5 hours 49 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 49 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 49 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 16 hours 39 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 27 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE